M Pharmaceutical Inc. (DB:T3F2) entered into a letter of intent to acquire the assets of 40 J's, LLC for CAD 4.7 million in cash and stock on January 4, 2017. M Pharmaceutical will issue approximately 80 million shares and will pay CAD 1.5 million in cash to be issued or paid over the next two years, together with certain milestone payments. M Pharmaceutical will acquire 100% of the worldwide rights to these products and technologies. The transaction is subject to due diligence, exchange approval and other normal closing requirements for the transaction. As of February 10, 2017, definitive documents for the 40 J’s acquisition are currently being reviewed by attorneys with signing and closing is anticipated by mid of February 2016.